Ethyl 2-hydroxy-6-[2-(oxomethylidene)-1-phenylmethoxypiperidin-4-yl]hexanoate
C21H29NO5 — CID 88657926
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 2-hydroxy-6-[2-(oxomethylidene)-1-phenylmethoxypiperidin-4-yl]hexanoate
Ethyl 2-hydroxy-6-[2-(oxomethylidene)-1-phenylmethoxypiperidin-4-yl]hexanoate (PubChem CID 88657926) has the molecular formula C21H29NO5 and a molecular weight of 375.47 g/mol. Its IUPAC name is ethyl 2-hydroxy-6-[2-(oxomethylidene)-1-phenylmethoxypiperidin-4-yl]hexanoate.
Molecular Properties
| Compound Name | Ethyl 2-hydroxy-6-[2-(oxomethylidene)-1-phenylmethoxypiperidin-4-yl]hexanoate |
|---|---|
| PubChem CID | 88657926 |
| Molecular Formula | C21H29NO5 |
| Molecular Weight | 375.47 g/mol |
| Exact Mass | 375.20 |
| IUPAC Name | ethyl 2-hydroxy-6-[2-(oxomethylidene)-1-phenylmethoxypiperidin-4-yl]hexanoate |
| SMILES | CCOC(=O)C(O)CCCCC1CCN(OCc2ccccc2)C(=C=O)C1 |
| InChI | InChI=1S/C21H29NO5/c1-2-26-21(25)20(24)11-7-6-8-17-12-13-22(19(14-17)15-23)27-16-18-9-4-3-5-10-18/h3-5,9-10,17,20,24H,2,6-8,11-14,16H2,1H3 |
| InChIKey | GSLLJUMPRFIKHG-UHFFFAOYSA-N |
| XLogP | 3.03 |
| TPSA | 76.07 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 375.47 |
| LogP ≤ 5 | 3.03 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'ketene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 88657926 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.